139 related articles for article (PubMed ID: 22584100)
1. Trends in drug-resistant tuberculosis in a gold-mining workforce in South Africa, 2002-2008.
van Halsema CL; Fielding KL; Chihota VN; Lewis JJ; Churchyard GJ; Grant AD
Int J Tuberc Lung Dis; 2012 Jul; 16(7):967-73. PubMed ID: 22584100
[TBL] [Abstract][Full Text] [Related]
2. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
[TBL] [Abstract][Full Text] [Related]
3. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
[TBL] [Abstract][Full Text] [Related]
4. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
[TBL] [Abstract][Full Text] [Related]
6. Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.
Schaaf HS; Garcia-Prats AJ; du Preez K; Rautenbach C; Hesseling AC
Int J Tuberc Lung Dis; 2016 Sep; 20(9):1249-56. PubMed ID: 27510254
[TBL] [Abstract][Full Text] [Related]
7. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
8. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
[TBL] [Abstract][Full Text] [Related]
9. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
10. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
[TBL] [Abstract][Full Text] [Related]
11. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
13. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.
Fairlie L; Beylis NC; Reubenson G; Moore DP; Madhi SA
BMC Infect Dis; 2011 Jan; 11():28. PubMed ID: 21269475
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
16. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
Liu Z; Shilkret KL; Finelli L
Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
20. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
